| The biology, function, and applications of exosomes in cancer J Liu, L Ren, S Li, W Li, X Zheng, Y Yang, W Fu, J Yi, J Wang, G Du Acta Pharmaceutica Sinica B 11 (9), 2783-2797, 2021 | 282 | 2021 |
| Apolipoproteins and cancer L Ren, J Yi, W Li, X Zheng, J Liu, J Wang, G Du Cancer medicine 8 (16), 7032-7043, 2019 | 110 | 2019 |
| Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis Q Tang, L Ren, J Liu, W Li, X Zheng, J Wang, G Du Cell Proliferation 53 (1), e12706, 2020 | 91 | 2020 |
| The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy X Zheng, W Li, L Ren, J Liu, X Pang, X Chen, D Kang, J Wang, G Du Pharmacology & therapeutics 195, 85-99, 2019 | 89 | 2019 |
| Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway X Zheng, W Li, H Xu, J Liu, L Ren, Y Yang, S Li, J Wang, T Ji, G Du Acta Pharmaceutica Sinica B 11 (11), 3465-3480, 2021 | 75 | 2021 |
| 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase W Li, J Liu, W Fu, X Zheng, L Ren, S Liu, J Wang, T Ji, G Du Journal of Experimental & Clinical Cancer Research 37, 1-15, 2018 | 66 | 2018 |
| miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway W Li, J Yi, X Zheng, S Liu, W Fu, L Ren, L Li, DSB Hoon, J Wang, G Du Clinical epigenetics 10, 1-14, 2018 | 63 | 2018 |
| Tumorigenic bacteria in colorectal cancer: mechanisms and treatments S Li, J Liu, X Zheng, L Ren, Y Yang, W Li, W Fu, J Wang, G Du Cancer biology & medicine 19 (2), 147, 2022 | 62 | 2022 |
| MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma Q Tang, W Li, X Zheng, L Ren, J Liu, S Li, J Wang, G Du Signal transduction and targeted therapy 5 (1), 279, 2020 | 55 | 2020 |
| Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle L Ren, W Li, X Zheng, J Liu, Y Yang, S Li, S Zhang, W Fu, B Xiao, J Wang, ... Acta Pharmacologica Sinica 43 (1), 194-208, 2022 | 46 | 2022 |
| Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer J Yi, L Ren, J Wu, W Li, X Zheng, G Du, J Wang Annals of Translational Medicine 7 (16), 2019 | 45 | 2019 |
| CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis L Ren, Y Yang, W Li, X Zheng, J Liu, S Li, H Yang, Y Zhang, B Ge, ... Journal of translational medicine 20 (1), 444, 2022 | 41 | 2022 |
| Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers J Yi, L Ren, D Li, J Wu, W Li, G Du, J Wang Biomedicine & Pharmacotherapy 124, 109827, 2020 | 37 | 2020 |
| 3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma W Li, L Ren, X Zheng, J Liu, J Wang, T Ji, G Du Acta Pharmaceutica Sinica B 10 (2), 301-312, 2020 | 33 | 2020 |
| Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis X Zheng, W Chen, J Yi, W Li, J Liu, W Fu, L Ren, S Li, B Ge, Y Yang, ... Acta Pharmacologica Sinica 43 (11), 2977-2992, 2022 | 30* | 2022 |
| Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest J Liu, W Fu, X Zheng, W Li, L Ren, J Wang, C Yang, G Du Acta Pharmacologica Sinica 42 (1), 97-107, 2021 | 29 | 2021 |
| Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening L Ren, X Zheng, J Liu, W Li, W Fu, Q Tang, J Wang, G Du Journal of Ethnopharmacology 242, 112044, 2019 | 29 | 2019 |
| Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis L Ren, J Yi, Y Yang, W Li, X Zheng, J Liu, S Li, H Yang, Y Zhang, B Ge, ... Pharmacological Research 183, 106376, 2022 | 28 | 2022 |
| ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH/PSAT1/serine metabolic pathway S Li, H Yang, W Li, J Liu, L Ren, Y Yang, B Ge, Y Zhang, W Fu, X Zheng, ... Acta Pharmacologica Sinica 43 (10), 2709-2722, 2022 | 21 | 2022 |
| Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer W Li, X Zheng, L Ren, W Fu, J Liu, J Xv, S Liu, J Wang, G Du Annals of translational medicine 7 (23), 2019 | 19 | 2019 |
